Business · 12/09/2014Updated: 10/17/2026 · 1 min read
FDA Withdraws Approval of Propoxyphene Products
Summary
The Food and Drug Administration (FDA) has withdrawn approval of three abbreviated new drug applications for propoxyphene-containing products due to safety concerns, specifically the risk of potentially serious heart rhythm abnormalities.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →